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Abstract
Background: There is inadequate evidence for the carcinogenicity of cobalt and cobalt compounds in humans.
Consequently, the International Agency for Research on Cancer (IARC) has evaluated cobalt metal without tungsten
carbide as possibly carcinogenic to humans (Group 2B). The aim of the study was to assess the risk of cancer
among workers employed in a Finnish cobalt plant since the beginning of production in 1968.
Methods: The study cohort consisted of all males employed by the Finnish cobalt plant for at least a year during
1968–2004. The follow-up for cancer was performed by studying the files of the Finnish Cancer Registry, using
personal identity codes as a key. The cohort was divided into subcohorts by exposure levels. Standardised
incidence ratios (SIRs) and 95% confidence intervals (95% CIs) were calculated as ratios of the observed numbers of
cancer cases and the numbers expected on the basis of incidence rates in the population of the same region.
Results: The follow-up cohort consisted of 995 men with 26,083 person-years. During the follow-up period, 92
cases of cancer were diagnosed (SIR 1.00, 95% CI 0.81–1.22), six of which were lung cancer cases (SIR 0.50; 95% CI
0.18–1.08). The only cancer type with increased incidence was tongue cancer (three cases, SIR 7.39; 95% CI 1.52–21.6).
We observed no dose-response effect across the different exposure levels and the incidence of any cancer type.
Conclusions: The results suggest that occupational exposure to cobalt is not associated with an increased overall
cancer risk or lung cancer risk among cobalt workers. Because of the small number of cancer cases the results must be
interpreted with caution.
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Background
Workers may be exposed to cobalt during the production
of cobalt and cobalt salts, in the production of alloys and
hard metal, drying agents, pigments and catalysts, and
during diamond polishing. World production of refined
cobalt has increased steadily over the last decade, due
partly to new operations and partly to a net increase in
production by established producers [1]. World cobalt
mine production in 2001 was 36,700 tons and the cobalt
refinery production 38,400 tons [2]. The respective
numbers in 2016 were 123,000 tons and 91,300 tons [3].
In the United States, more than a million workers are
potentially exposed to cobalt and its compounds [4]. In
Finland, about 1500 workers (0.1% of employed people)
are estimated to be exposed to cobalt or cobalt
compounds at work [5].
Different epidemiological studies provide relatively
sparse and contradictory data on the carcinogenicity of
cobalt to humans. A Swedish study retrospectively
followed a cohort of 3000 cobalt workers in 1951–1982
[6]. It found a non-significant increase in mortality from
lung cancer in the whole cohort (SMR 1.34, 95% CI
0.77–2.13). A significant excess mortality from lung
cancer was found among workers with over ten years of
employment who had died more than 20 years after the
end of exposure (SMR 2.78, 95% CI 1.11–5.72). Early
findings from a French study in the 1980s suggested
increased mortality from cancers of the trachea, lung
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and bronchus among cobalt workers (SMR 4.66; 95% CI
1.46–10.64) [7]. However, the results were based on only
four cases. In their follow-up study of the same popula-
tion, Moulin et al. [8] could not confirm the previous
results. A Norwegian study in a nickel refinery did not
find any increase in risk of lung cancer from cobalt
exposure [9].
The results of the studies on the carcinogenicity of co-
balt vary according to the kind of industry in which the
exposed workers are employed. Increased mortality from
lung cancer has been found among workers in the hard
metal industry [10]. In addition to cobalt, hard metal also
contains tungsten carbide. According to the International
Agency for Research on Cancer (IARC) the carcinogen-
icity of cobalt metal with tungsten carbide was evaluated
as probably carcinogenic to humans (Group 2A), whereas
cobalt metal without tungsten carbide was evaluated as
possibly carcinogenic to humans (Group 2B). Cobalt
sulphate and other soluble cobalt (II) salts were also evalu-
ated as possibly carcinogenic to humans (Group 2B) [1].
In early 2014, the Netherlands Competent Authority
(RIVM) notified its intention via the Registry of Intent
to prepare an EU-harmonised classification and labelling
proposal on ‘cobalt metal and other cobalt compounds
(to be determined)’. European Commission is actively
fighting against occupational cancer and aiming to
amend the Carcinogens and Mutagens Directive [11]. It
is important to have up-to-date scientific evidence based
data as a background of legislation.
The purpose of this study was to assess the risk of
cancer among workers employed in a Finnish cobalt
plant, using the company’s employment records, expos-
ure data, and data from the Finnish Cancer Registry. On
the basis of this reliable data, we aimed to add to the
knowledge on the carcinogenicity of cobalt without
tungsten carbide in occupational settings.
Methods
This is a retrospective cohort study. The study cohort was
made up of all males employed for at least one year at the
Kokkola cobalt plant (Freeport Cobalt Oy) during the
period 1968–2004. The cohort of 1004 men was identified
from the company’s employment records. The correct
personal identity codes (PICs), vital status and possible
dates of emigration or death were searched from the
national Population Register Center. Nine men (0.9%)
were not found in the population register and were ex-
cluded, leaving 995 workers in the final cohort (Table 1).
Since 1967, all Finnish residents have had a unique PIC,
which is used in all main registers in Finland. The PIC en-
ables reliable automatic record linkage.
We used PICs as keys in the follow-up for cancer
through the files of the population-based nationwide
Finnish Cancer Registry. Follow-up began on the date
when the person had been working for one year at the
Kokkola cobalt plant, and ended at emigration, death or
on 31 December 2013, whichever came first. We also
calculated the cancer risk as starting from the date when
a person had worked for five years at the cobalt plant.
The numbers of observed cases and person-years at
risk were counted, in five-year age groups and five-year
calendar periods. The expected numbers of cases for
total cancer and for specific cancer types were calculated
by multiplying the number of person-years in each
stratum by the corresponding cancer incidence among
men in the central hospital catchment area of Central
Ostrobothnia around the Kokkola cobalt plant.
Table 1 Number of male workers (N) in cobalt plant cohort,
and person-years during 1969–2013, by age and exposure
group (for definitions, see Table 2). The numbers in the
N column in different age groups refer to the age at the
beginning of follow-up
N Person-years
Total 995 26,083.2
High exposure 380 11,254.9
Age (years)
15–29 269 1480.0
30–44 103 4243.6
45–59 7 3663.5
60–74 1 1736.5
75+ - 131.6
Moderate exposure 159 2823.4
Age (years)
15–29 122 563.4
30–44 35 1378.4
45–59 2 674.8
60–74 - 205.8
75+ - 1.0
Low exposure 364 9966.7
Age (years)
15–29 275 1431.2
30–44 81 3903.3
45–59 8 2987.7
60–74 - 1522.6
75+ - 121.9
Variable exposure with peak exposures 110 2174.1
Age (years)
15–29 94 475.9
30–44 16 960.6
45–59 - 551.2
60–74 - 182.8
75+ - 3.7
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To calculate the standardised incidence ratio (SIR), the
observed number of cases was divided by the expected
number. The 95% confidence interval (95% CI) for the
SIR was based on the assumption that the number of
observed cases followed a Poisson distribution.
A non-commercial software program of Finnish
Cancer Registry was used for statistical analysis. We call
an SIR as “statistically significant” if its 95% confidence
interval does not include value 1.0.
Workplace exposures
Between 1966 and 1987, cobalt powder was produced
from pyrite ore concentrate at the Kokkola cobalt plant.
After 1987, cobalt powder, inorganic cobalt, and nickel
compounds have been produced using by-products of
the metallurgic industry as raw material (Fig. 1).
In sulphatising roasting, dust in the ambient air was
found to contain 15–20% iron, 1% zinc, 0.4% cobalt, and
0.2% nickel, whereas in leaching building, the dust
consisted of metal sulphides and sulphates. The highest
exposure levels of nickel (0.12 mg/m3) were measured in
the chemical department during 1987–1999, otherwise
exposure levels have been ≤0.04 mg/m3. Cobalt and
nickel were present as water-soluble sulphates. In the re-
duction plant and powder production facility, cobalt is
mainly in the form of cobalt powder and fine powder. In
the chemical department, the cobalt and nickel com-
pounds were mainly sulphates, carbonates, oxides, and
hydroxides.
Total exposure to dust, cobalt, nickel, sulphur dioxide,
hydrogen sulphide, and ammonia has been regularly
monitored several times a year since 1966, as both sta-
tionary measurements and personal samples. The mean
exposure level of total dust was high in the sulphatising
roasting department, at 8.5 mg/m3. The mean levels of
cobalt in the workplace air in 1967–2003 are presented
in Fig. 2. The methods of measuring workplace expo-
sures have been described in detail earlier [12, 13].
According to biological monitoring surveillance, the
highest exposure to cobalt was in the reduction and
powder production department. The highest urinary
content of cobalt was about 16,000 nmol/l (level of
unexposed persons being <40 nmol/l). In the solution
purification and chemical departments, the urinary
cobalt levels were between 200 and 2000 nmol/l. Respira-
tors were available since the plant started operating, and
became mandatory in the last ten years in the powder
production and chemical departments. The biological
monitoring results show that exposure is still considerable,
despite the intensified use of respirators [12, 13].
Exposure groups
The cohort was divided into subcohorts by exposure
levels, according to the department in which they had
started working during their employment at the plant
(Tables 1, 2). The exposure in different departments was
classified according to the industrial hygienic measure-
ments (Fig. 2) and biological monitoring. Exposure in
factory maintenance was classified as variable, because it
includes e.g. repairs in different departments with possible
peak exposures when the machinery is out of order.
Results
The follow-up cohort consisted of 995 men with 26,083
person-years (Table 1). The mean follow-up of a person
was thus 26.2 years.
Cobalt process 1966 – 1987 Cobalt process 1987 – present
Pyrite ore concentration Cobalt concentrates
Iron residue Iron residue
Copper sulphide
Zinc sulphide
Copper sulphide
Zinc sulphide
Nickel ammonium 
sulphate
Cobalt and 
nickel solutions          
Cobalt powder
Cobalt fine powder
Sulphatising
roasting
Leaching and
solution purification
Reduction and
powder production
Leaching and
solution
purification
Cobalt
extraction
Chemical
production
Reduction and
powder 
production
Cobalt powder
Cobalt fine powder
Cobalt and nickel 
sulphates, oxides, 
hydroxides
Fig. 1 Cobalt production process in the Kokkola cobalt plant in 1966 – 1987 and 1987 – present
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During the follow-up period, 92 cases of cancer were
diagnosed, and the expected number was 91.9 (SIR 1.00,
95% CI 0.81–1.22; Table 3). Five cases were observed
5–15 years after the beginning of follow-up and 87 cases
more than 15 years after the beginning of follow-up.
A total of 77 cases of cancer were diagnosed among
men who had been working in the plant for over five
years (SIR 1.08, 95% CI 0.85–1.34) (Table 3). The overall
cancer incidence was not significantly elevated in any of
the exposure groups (Table 4).
The SIR for lung cancer among men with at least one
year of employment was 0.50 (95% CI 0.18–1.08) and
among men with at least five years of employment 0.52
(95%CI 0.17–1.22) (Table 3). None of the exposure
group-specific SIRs for lung cancer was significantly dif-
ferent from 1.0 (Table 4). Three of the lung cancer cases
were in the age group 45–59 years and three in the age
group 60–74 years. The age specific SIRs for lung cancer
did not differ significantly from those of the reference
population (age group 45–59 years: SIR 0.75, 95% CI
0.15–2.18 and age group 60–74 years: SIR 0.42, 95% CI
0.09–1.24).
The incidence of tongue cancer was significantly in-
creased (SIR 7.39; 95% CI 1.52–21.6) (Table 3). The age
of the patients at the time of diagnosis was 39, 52 and
70 years. The age group specific SIRs for tongue cancer
did not differ significantly from those of the reference
population (age group 30–44 years: SIR 16.35, 95% CI
0.41–91.08; age group 45–59 years: SIR 8.02, 95% CI
0.20–44.66 and age group 60–74 years: SIR 16.23, 95%
CI 0.41–90.40). All three cases were smokers. One of
them had worked for 20.5 years in the cobalt plant
(variable exposure group), one had worked there for
36.1 years (low exposure group) and the third for
15.8 years (high exposure group).
There was an excess of bladder cancer cases in the low
exposure group (SIR 3.07; 95% CI 1.12–6.67) (Table 4).
One bladder cancer patient was a non-smoker, four were
smokers and the smoking status of four patients was
unknown. The SIRs for stomach cancer, larynx cancer
and thyroid cancer exceeded 2.0 but were based on small
numbers of cases and were not statistically significant
(Table 3).
Discussion
Early findings from a French study in the 1980s sug-
gested that cobalt workers may be at an increased risk of
cancers of the trachea, lung and bronchus [7]. Later
findings indicated that occupational exposure to cobalt
in the ambient air does not increase either the total
cancer risk or the risk of lung cancer [8]. The results of
the present study are in line with the no-increase
findings. In the present study of a cohort of 995 men
working in a cobalt plant, with a mean follow-up of
26.2 years, we observed no elevated overall cancer
incidence or elevated incidence of lung cancer.
Our cohort consisted of all employees who had been
working in the integrated production unit of the
Kokkola cobalt plant during 1969–2004. Identification of
cohort members and follow-up for deaths and emigra-
tion were complete for the period of this study. The
completeness of cancer registration in Finland is at least
99% [14], and the computerised record linkage proced-
ure precise [15]. Therefore, technical incompleteness
does not cause bias in the results.
Exposure assessment
The mean levels of cobalt in the ambient air in this plant
were generally at the level of the current occupational
exposure limit in Finland (0.02 mg/m3). During the first
years of cobalt production, the cobalt levels may have
been considerably higher, over 1 mg/m3, especially in
the roasting department. The Finnish occupational limits
were also often exceeded in the reduction and powder
production departments.
Cobalt exposure was monitored with exceptional
accuracy from the early days of the studied plant. The
working history of the patients was verified from the
registers, which minimises recall and information bias.
This was not the case in previous epidemiological
studies, which did not report either the exposure levels
of cobalt or simultaneous co-exposures [7].
Of the other simultaneous co-exposures, nickel is con-
sidered as carcinogenic. There has been nickel exposure
Fig. 2 Mean cobalt exposure levels at Kokkola cobalt plant in 1968–2014
Table 2 Exposure groups according to departments
Definition Departments
Variable exposure with peak
exposures
Factory maintenance
Low exposure Leaching and solution purification
Moderate exposure Chemical department, test plant
High exposure Sulphatising roasting, reduction
and powder production
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in leaching, solution, purification and chemical depart-
ments. In a recent study on cancer risk in a Finnish nickel
refinery the increased lung cancer and sinonasal cancer
risk was found in the most nickel-exposed work site where
the nickel concentration had been ≥0.2 mg/m3 [16]. The
nickel exposure levels have been much lower in the cobalt
plant than in the nickel refinery, and in the present study
there were no sinonasal cancers and the risk of lung
cancer was low.
SIR
The previous epidemiological studies on the carcinogen-
icity of cobalt used the standardised mortality ratio
(SMR) as a measure of cancer risk, comparing the
number of deaths in the cohort with the expected num-
ber of deaths, calculated from the mortality rates of the
general population [7, 8, 10]. As the majority of cancer
patients die from non-cancer causes of death, the SIR is
a more sensitive way of analysing the effects of cobalt
than the SMR.
Overall cancer
The overall cancer incidence was not elevated in the
present study. We used the incidence rates of the
population of Central Ostrobothnia Finland as the main
reference, because incidence rates vary geographically.
Table 3 Observed (Obs) and expected (Exp) numbers of cancer cases and standardised incidence ratios (SIR) with 95% confidence
intervals (CI) among male workers at the Kokkola cobalt plant during 1969–2013, by site and duration of employment. Only primary
sites with ≥2 observed or expected cancer cases included
Primary site Employment >1 year Employment >5 years
Obs Exp SIR 95% CI Obs Exp SIR 95% CI
All sites 92 91.9 1.00 0.81–1.22 77 71.6 1.08 0.85–1.34
Tongue 3 0.41 7.39 1.52–21.6 3 0.30 10.0 2.06–29.2
Oesophagus 2 1.15 1.74 0.21–6.28 2 0.89 2.24 0.27–8.08
Stomach 7 3.47 2.01 0.81–4.15 5 2.73 1.83 0.59–4.26
Colon 4 4.36 0.92 0.25–2.34 4 3.46 1.16 0.32–2.96
Rectum, rectosigmoid 4 3.80 1.05 0.29–2.69 3 2.93 1.03 0.21–2.99
Pancreas 2 3.44 0.58 0.07–2.09 1 2.69 0.37 0.01–2.07
Larynx, epiglottis 2 0.81 2.45 0.30–8.86 2 0.65 3.09 0.37–11.2
Lung, trachea 6 12.0 0.50 0.18–1.08 5 9.55 0.52 0.17–1.22
Melanoma of the skin 1 3.29 0.30 0.01–1.69 1 2.53 0.39 0.01–2.20
Skin, non-melanoma 3 2.78 1.08 0.22–3.15 3 2.22 1.35 0.28–3.94
Basal cell carcinoma of the skin 18 19.2 0.94 0.56–1.48 12 15.1 0.80 0.41–1.38
Prostate 33 24.4 1.35 0.93–1.89 26 19.4 1.34 0.87–1.96
Kidney 2 3.81 0.52 0.06–1.89 2 3.00 0.67 0.08–2.40
Bladder and urinary tract 9 4.79 1.88 0.86–3.56 6 3.76 1.60 0.59–3.47
Brain, central nervous system 2 2.82 0.71 0.09–2.56 2 2.07 0.97 0.12–3.49
Thyroid gland 2 0.99 2.01 0.24–7.26 2 0.72 2.78 0.34–10.0
Non-Hodgkin lymphoma 3 4.44 0.68 0.14–1.97 3 3.42 0.88 0.18–2.56
Leukaemia 3 2.11 1.42 0.29–4.15 3 1.58 1.90 0.39–5.54
Table 4 Observed (Obs) and expected (Exp) numbers of cancer cases (all sites, lung and nasal cancer) and standardised incidence
ratios (SIR) with 95% CI during 1967–2011 among workers in the Kokkola cobalt plant during 1969–2013with employment of >1 year, by
exposure group
Exposure
group
All sites Lung, trachea Tongue Bladder
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI
Variable 7 5.02 1.39 0.56–2.87 - 0.55 0.00 0.00–6.68 1 0.04 26.4 0.67–14.0 - 0.25 0.00 0.00–15.0
Low 42 37.8 1.11 0.80–1.50 2 4.89 0.41 0.05–1.47 1 0.15 6.48 0.16–36.1 6 1.96 3.07 1.12–6.67
Moderate 4 6.02 0.66 0.18–1.70 - 0.66 0.00 0.00–5.56 - 0.06 0.00 0.00 - 0.30 0.00 0.00–12.2
High 39 43.6 0.90 0.64–1.22 4 5.95 0.67 0.18–1.72 1 0.16 6.12 0.15–34.1 3 2.32 1.30 0.27–3.78
Total 92 91.9 1.00 0.81–1.22 6 12.0 0.50 0.18–1.08 3 0.41 7.39 1.52–21.6 9 4.79 1.88 0.86–3.56
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Cancer incidence also varies according to socioeconomic
position. The majority of the workers in the departments
of the Kokkola cobalt plant were skilled blue-collar
workers, whereas the reference group included all socio-
economic groups. It is known that the cancer incidence
of blue-collar workers in most cancer types is close to
the population average [17], and hence, the reference
rates used in our calculations of expected numbers of
cases should be valid.
Healthy worker effect is a phenomenon initially
observed in studies of occupational diseases: workers
usually exhibit lower overall death rates than the general
population because the severely ill and chronically
disabled are ordinarily excluded from employment [18].
The healthy worker effect might also affect cancer inci-
dence in the first years after employment but the effect
is much smaller than it would be in a study on mortality.
In the Kokkola cobalt plant there was no selection of
workers because of possible cancer risk. No markers or
tests were used in pre-employment health examinations
of the plant to exclude individuals that could be in risk
of cancer. We could follow the workers also after the
end of employment. Thus, if they had to leave work
because of health reasons, they were still included in our
cohort. Therefore, we suggest that healthy worker effect
did not play a marked role in this study.
A dose-response relationship between exposure level
of cobalt and cancer incidence would have supported
the idea of cobalt as a causative agent of the cancers.
However, the overall cancer incidence did not increase
according to the cobalt exposure level.
Lung cancer
In the present study, the incidence of lung cancer cases
decreased by 50%, and even more among the cohort
members who had been working in the same depart-
ment for more than five years.
A French study [7] found an increased SMR for lung
cancer among cobalt workers, but a follow-up study of
the same cohort with an extended observation period
could not verify the previous results [8]. In that French
study, the exposing compounds were quite comparable
to those in our study, but the exposure levels were not
known.
Tongue cancer
The total study group contained three cases of tongue
cancer. The SIR for tongue cancer was significantly higher
in the total group (7.39, 95% CI 1.52–21.60). In different
exposure or age groups the increase was not statistically
significant. To our knowledge, no previous studies have
associated cobalt exposure with tongue cancer. According
to the literature, the most significant risk factors for oral
cancer are smoking and alcohol use [19, 20]. All three
cases of tongue cancer in our cohort were smokers. We
do not have data on their alcohol consumption.
Interaction of different carcinogenic metals could be a
hypothetical explanation for the excess of tongue cancers.
However, none of the tongue cancer patients had worked
in the chemical department where the nickel exposure
was highest, but tobacco smoke contains also different
metals including aluminium, cadmium, chromium, nickel,
lead, mercury, selenium, vanadium, manganese and zinc
[21], which may have synergistic effects with cobalt ex-
posure. Metals are thought to promote cancer by a num-
ber of common mechanisms. In terms of direct damage to
DNA, most metals are only weakly mutagenic; however,
many are strong co-carcinogens, promoting a synergistic
effect in the presence of other cancer-causing agents [22].
Because the small number of tongue cases here, the excess
may be explained by chance alone.
Cancer of urinary bladder
Nine cases were bladder cancer, which is nearly twice
the expected number, but the difference was not statisti-
cally significant. However, the lowest exposure group
had a statistically significant three-fold excess of urinary
bladder cancer cases. All in all, 2/3 of the cases were
from the lowest exposure category. The most important
risk factor for bladder cancer is tobacco smoking [23].
Only one bladder cancer patient was a non-smoker out
of five cases with known smoking status. Occupationally,
aromatic amines are known to cause bladder cancer as
an occupational disease [24]. No one in this study group
was known to have been exposed to aromatic amines.
Smoking
The most important source of incomparability between
the results derived from different cohorts is usually
confounding due to smoking, which has not been
controlled for in most studies and which may lead to a
bias in a different direction, depending on whether
smoking in the cohort is lower or higher than in the
reference population. According to data gathered in
2000, the prevalence of current smokers among the em-
ployees of the Kokkola cobalt plant was 31.8% [13]. The
prevalence of daily smokers in the male population in
the province of Central Ostrobothnia around the cobalt
plant in 1990–2005 varied from 18% in the highest
educational class to 25% in the lowest [25]. These
percentages may be an underestimation of smokers,
possibly due to the small sample size. During this same
time period, the prevalence of daily smokers in the
whole country was about 30% [25]. Moreover, daily
smokers and current smokers may represent different
groups. Hence, the explanation of the SIR 0.5 for lung
cancer in our cohort is apparently not a lower smoking
prevalence as compared to the reference population.
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Different effects of different compounds
An assessment of cobalt and its compounds requires a
clear distinction between different compounds and
needs to take into account the different mechanisms in-
volved. There is evidence that soluble cobalt (II) cations
exert genotoxic and carcinogenic activity both in vitro
and in vivo in experimental systems [26, 27]. There is
also evidence that hard metal particles that contain
tungsten carbide, in addition to cobalt, exert genotoxic
and carcinogenic activity in vitro and in human studies
[28]. However, the conclusion of IARC (2006) is that the
evidence is limited in humans for increased risk of lung
cancer in case of cobalt with tungsten carbide and inad-
equate in case of cobalt without tungsten carbide [1].
For carcinogenicity of cobalt oxides and other com-
pounds there is insufficient information [28].
Conclusions
The results suggest that occupational exposure to cobalt is
not associated with an increased overall cancer risk or
lung cancer risk among cobalt workers. Unexpectedly we
found a significant increase in the incidence of tongue
cancer. There are no previous data from either animal or
human studies to support an association between cobalt
and tongue cancer. Because of the small number of cancer
cases the results must be interpreted with caution.
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